These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10699336)

  • 1. Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies.
    Pawlowski A; Källenius G; Svenson SB
    Vaccine; 2000 Mar; 18(18):1873-85. PubMed ID: 10699336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM(197) conjugate vaccines in a murine model.
    Mawas F; Feavers IM; Corbel MJ
    Vaccine; 2000 Dec; 19(9-10):1159-66. PubMed ID: 11137252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity.
    McCool TL; Harding CV; Greenspan NS; Schreiber JR
    Infect Immun; 1999 Sep; 67(9):4862-9. PubMed ID: 10456942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response.
    Rodriguez ME; van den Dobbelsteen GP; Oomen LA; de Weers O; van Buren L; Beurret M; Poolman JT; Hoogerhout P
    Vaccine; 1998 Dec; 16(20):1941-9. PubMed ID: 9796048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
    Jalah R; Torres OB; Mayorov AV; Li F; Antoline JF; Jacobson AE; Rice KC; Deschamps JR; Beck Z; Alving CR; Matyas GR
    Bioconjug Chem; 2015 Jun; 26(6):1041-53. PubMed ID: 25970207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron beam fragmentation of bacterial polysaccharides as a method of producing oligosaccharides for the preparation of conjugate vaccines.
    Pawlowski A; Svenson SB
    FEMS Microbiol Lett; 1999 May; 174(2):255-63. PubMed ID: 10339817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenyl linker markedly increases the immunogenicity of the pneumococcal polysaccharide conjugate vaccine.
    Wei D; Yu W; Hu C; Shen L; Hu T
    Biotechnol Lett; 2018 Aug; 40(8):1263-1270. PubMed ID: 29802568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune response of a pneumococcal conjugate vaccine: capsular polysaccharide serotype 14-Lysine modified PspA.
    Santamaria R; Goulart C; Perciani CT; Barazzone GC; Carvalho R; Gonçalves VM; Leite LC; Tanizaki MM
    Vaccine; 2011 Nov; 29(47):8689-95. PubMed ID: 21906649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine.
    Qiao W; Ji S; Zhao Y; Hu T
    Vaccine; 2015 Apr; 33(17):2066-72. PubMed ID: 25728319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help.
    Khan AQ; Lees A; Snapper CM
    J Immunol; 2004 Jan; 172(1):532-9. PubMed ID: 14688364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
    Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
    J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.
    Lagergard T; Shiloach J; Robbins JB; Schneerson R
    Infect Immun; 1990 Mar; 58(3):687-94. PubMed ID: 2407652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of the Process for Preparing Bivalent Polysaccharide Conjugates to Develop Multivalent Conjugate Vaccines against Streptococcus pneumoniae or Neisseria meningitidis and Comparison with the Corresponding Licensed Vaccines in Animal Models.
    Huang F; Jing XB; Li YB; Wang Q; Liu SL; Yang ZR; Feng S
    Curr Med Sci; 2023 Feb; 43(1):22-34. PubMed ID: 36680685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein.
    Michon F; Fusco PC; Minetti CA; Laude-Sharp M; Uitz C; Huang CH; D'Ambra AJ; Moore S; Remeta DP; Heron I; Blake MS
    Vaccine; 1998 Nov; 16(18):1732-41. PubMed ID: 9778749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of PEG-hexadecane markedly increases the immunogenicity of pneumococcal polysaccharide conjugate vaccine.
    Chang X; Yu W; Ji S; Shen L; Tan A; Hu T
    Vaccine; 2017 Mar; 35(13):1698-1704. PubMed ID: 28242069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults.
    Wuorimaa T; Käyhty H; Leroy O; Eskola J
    Vaccine; 2001 Feb; 19(15-16):1863-9. PubMed ID: 11228355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein.
    Kamboj KK; Kirchner HL; Kimmel R; Greenspan NS; Schreiber JR
    J Infect Dis; 2003 May; 187(10):1629-38. PubMed ID: 12721943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.